BioNTech

Headquarters in Mainz BioNTech SE ( ; or short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Provided by Wikipedia
Showing 1 - 8 results of 8 for search 'BioNTech SE', query time: 0.04s Refine Results
In addition to media from the THWS, media from other Bavarian libraries are also displayed.
These are marked with the "Interlibrary loan" label and can be ordered by clicking on them.
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8